Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2018-2033)
2.2 Personalized Medicines In Oncology Growth Trends by Region
2.2.1 Global Personalized Medicines In Oncology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Personalized Medicines In Oncology Historic Market Size by Region (2018-2023)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Region (2024-2033)
2.3 Personalized Medicines In Oncology Market Dynamics
2.3.1 Personalized Medicines In Oncology Industry Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2018-2023)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2022
3.5 Personalized Medicines In Oncology Key Players Head office and Area Served
3.6 Key Players Personalized Medicines In Oncology Product Solution and Service
3.7 Date of Enter into Personalized Medicines In Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2018-2023)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2024-2033)
5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2018-2023)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2018-2033)
6.2 North America Personalized Medicines In Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Personalized Medicines In Oncology Market Size by Country (2018-2023)
6.4 North America Personalized Medicines In Oncology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2018-2033)
7.2 Europe Personalized Medicines In Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Personalized Medicines In Oncology Market Size by Country (2018-2023)
7.4 Europe Personalized Medicines In Oncology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2018-2033)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2018-2033)
9.2 Latin America Personalized Medicines In Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Personalized Medicines In Oncology Market Size by Country (2018-2023)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2018-2033)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Detail
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Detail
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Detail
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Detail
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Detail
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Detail
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Detail
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Detail
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Detail
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Detail
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2018-2023)
11.12.5 Exagen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Personalized Medicines In Oncology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Personalized Medicines In Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Personalized Medicines In Oncology Market Share by Region (2018-2023)
Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Personalized Medicines In Oncology Market Share by Region (2024-2033)
Table 14. Personalized Medicines In Oncology Market Trends
Table 15. Personalized Medicines In Oncology Market Drivers
Table 16. Personalized Medicines In Oncology Market Challenges
Table 17. Personalized Medicines In Oncology Market Restraints
Table 18. Global Personalized Medicines In Oncology Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Personalized Medicines In Oncology Market Share by Players (2018-2023)
Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2022)
Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Personalized Medicines In Oncology Product Solution and Service
Table 25. Date of Enter into Personalized Medicines In Oncology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Medicines In Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2018-2023)
Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2024-2033)
Table 31. Global Personalized Medicines In Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2018-2023)
Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2024-2033)
Table 35. North America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Personalized Medicines In Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Personalized Medicines In Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Personalized Medicines In Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Personalized Medicines In Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Personalized Medicines In Oncology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Personalized Medicines In Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Personalized Medicines In Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 50. Biotheranostics Company Detail
Table 51. Biotheranostics Business Overview
Table 52. Biotheranostics Personalized Medicines In Oncology Product
Table 53. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 54. Biotheranostics Recent Development
Table 55. Illumina Company Detail
Table 56. Illumina Business Overview
Table 57. Illumina Personalized Medicines In Oncology Product
Table 58. Illumina Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 59. Illumina Recent Development
Table 60. DNA Link Company Detail
Table 61. DNA Link Business Overview
Table 62. DNA Link Personalized Medicines In Oncology Product
Table 63. DNA Link Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 64. DNA Link Recent Development
Table 65. Genomic Health, Inc.(Exact Sciences) Company Detail
Table 66. Genomic Health, Inc.(Exact Sciences) Business Overview
Table 67. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
Table 68. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 69. Genomic Health, Inc.(Exact Sciences) Recent Development
Table 70. Cypher Genomics(Human Longevity, Inc.) Company Detail
Table 71. Cypher Genomics(Human Longevity, Inc.) Business Overview
Table 72. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
Table 73. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 74. Cypher Genomics(Human Longevity, Inc.) Recent Development
Table 75. Life Technologies Corporation(Thermo Fisher Scientific) Company Detail
Table 76. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
Table 77. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
Table 78. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 79. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
Table 80. Fulgent Genetics Company Detail
Table 81. Fulgent Genetics Business Overview
Table 82. Fulgent Genetics Personalized Medicines In Oncology Product
Table 83. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 84. Fulgent Genetics Recent Development
Table 85. Caris Life Sciences Company Detail
Table 86. Caris Life Sciences Business Overview
Table 87. Caris Life Sciences Personalized Medicines In Oncology Product
Table 88. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 89. Caris Life Sciences Recent Development
Table 90. Ariana Pharma Company Detail
Table 91. Ariana Pharma Business Overview
Table 92. Ariana Pharma Personalized Medicines In Oncology Product
Table 93. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 94. Ariana Pharma Recent Development
Table 95. Abbott Laboratories Company Detail
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Personalized Medicines In Oncology Product
Table 98. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. deCODE genetics Company Detail
Table 101. deCODE genetics Business Overview
Table 102. deCODE genetics Personalized Medicines In Oncology Product
Table 103. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 104. deCODE genetics Recent Development
Table 105. Exagen Inc Company Detail
Table 106. Exagen Inc Business Overview
Table 107. Exagen Inc Personalized Medicines In Oncology Product
Table 108. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2018-2023) & (US$ Million)
Table 109. Exagen Inc Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicines In Oncology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Personalized Medicines In Oncology Market Share by Type: 2022 VS 2033
Figure 3. Molecular Oncopathology Features
Figure 4. Genome Diagnostics Features
Figure 5. Radiation Therapy Features
Figure 6. Oncology Testing Features
Figure 7. Chemotherapy Features
Figure 8. Others Features
Figure 9. Global Personalized Medicines In Oncology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Personalized Medicines In Oncology Market Share by Application: 2022 VS 2033
Figure 11. Research Centers Case Studies
Figure 12. Governmental Institutions Case Studies
Figure 13. Hospitals Case Studies
Figure 14. Clinical Centers Case Studies
Figure 15. Others Case Studies
Figure 16. Personalized Medicines In Oncology Report Years Considered
Figure 17. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Personalized Medicines In Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Personalized Medicines In Oncology Market Share by Region: 2022 VS 2033
Figure 20. Global Personalized Medicines In Oncology Market Share by Players in 2022
Figure 21. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2022
Figure 23. North America Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Personalized Medicines In Oncology Market Share by Country (2018-2033)
Figure 25. United States Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Personalized Medicines In Oncology Market Share by Country (2018-2033)
Figure 29. Germany Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2018-2033)
Figure 37. China Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Personalized Medicines In Oncology Market Share by Country (2018-2033)
Figure 45. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2018-2033)
Figure 49. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 52. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 53. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 54. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 55. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 56. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 57. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 58. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 59. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 60. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 61. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 62. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed